Showing results (141-150 of 668) with videos related to
Sort By:
Pageof 67
Advances in Pharmacology (San Diego, Calif.)|February 1, 2015
Significance of GABA(A) receptor heterogeneity: clues from developing neuronsJean-Marc FritschyAdvances in Pharmacology (San Diego, Calif.)|February 1, 2015
Mechanisms of fast desensitization of GABA(B) receptor-gated currentsAdi Raveh, Rostislav Turecek, Bernhard BettlerAdvances in Pharmacology (San Diego, Calif.)|August 11, 2022
Atypical kinetics of cytochrome P450 enzymes in pharmacology and toxicologyJacqueline Wen Hui Leow, Lloyd Wei Tat Tang, Eric Chun Yong ChanAdvances in Pharmacology (San Diego, Calif.)|August 11, 2022
Use of engineered cytochromes P450 for accelerating drug discovery and developmentRaine E S Thomson, Stephlina A D'Cunha, Martin A Hayes, et al.Advances in Pharmacology (San Diego, Calif.)|August 11, 2022
Assessing cytochrome P450 function using genetically engineered mouse modelsSarrah L Hannon, Xinxin DingAdvances in Pharmacology (San Diego, Calif.)|August 11, 2022
Polymorphic cytochromes P450 in non-human primatesYasuhiro Uno, Shotaro Uehara, Hiroshi YamazakiAdvances in Pharmacology (San Diego, Calif.)|August 11, 2022
Cytochrome P450 enzymes in the pediatric population: Connecting knowledge on P450 expression with pediatric pharmacokineticsChie Emoto, Trevor N JohnsonAdvances in Pharmacology (San Diego, Calif.)|March 1, 2023
Genetic and environmental reprogramming of the sarcoma epigenomeAnne Grand'Maison, Rachael Kohrn, Emmanuel Omole, et al.Advances in Pharmacology (San Diego, Calif.)|March 1, 2023
Epigenomic reprogramming in iAs-mediated carcinogenesisSmitha George, Richard N Cassidy, Wesley N Saintilnord, et al.Advances in Pharmacology (San Diego, Calif.)|February 10, 2025
Modulatory and protective effects of prolyl hydroxylase domain inhibitors in the central nervous systemKonstantinos Matheoudakis, John J O'ConnorPageof 67